KANZEN R&D
Through continuous research and development of Kanzen R&D Center,
we have applied for and Registration
12 domestic technology patents in
the fields of medicine and cosmetics.
| Name | Patent Number | Application Date | Category |
|---|---|---|---|
| Use as beta-lactamase inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) or its derivatives |
10-1953981 | 17.07.24 | Registration 19.02.25 |
| Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and screening method for detecting the same |
10-1877002 | 17.10.11 | Registration 18.07.04 |
| Peptide binding to trans-2-nonenal and aldehyde-based odor removal composition comprising the above peptide |
10-1993987 | 17.10.11 | Registration 19.06.21 |
| Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and screening method for detecting the same |
10-1867779 | 17.12.08 | Registration 18.06.07 |
| Composition comprising botulinum toxin and method for preparing same |
10-2247924 | 19.04.18 | Registration 21.04.28 |
| Composition comprising botulinum toxin and method for preparing same Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and method for detecting the same |
16/491,499 (Entry number) |
19.09.05 | |
| Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and screening method for detecting the same |
201580050749.X (Entry number) |
19.09.06 | Submission of opinion supplementary statement |
| Composition comprising botulinum toxin and method for preparing same Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and method for detecting the same |
18764324.2 (Entry number) |
19.10.04 | Submission of opinion supplementary statement |
| Pharmaceutical composition for preventing or treating pruritus containing pyrazole derivative as an active ingredient and method for detecting the same |
10-2017-28220 (Entry number) |
19.11.06 | |
| Novel cell-penetrating peptides and uses thereof | 10-2192191 | 19.12.06 | Registration 20.12.17 |
| Recombinant protein comprising botulinum toxin and cell-penetrating peptide and cosmetic composition comprising the same | 10-2192192 | 20.08.07 | Registration 20.12.17 |
| Hyaluronic acid production strain and hyaluronic acid production method using the same |
10-2249438 | 20.09.25 | Registration 21.04.30 |
by CDP technology
By combining with existing materials that were difficult to penetrate into the skin, CDP technology with amazing penetrating power suggests
various skin penetrating application technologies.
We lead the bio skin care industry as a leader
in skin penetration applications through the combination of Kanzen's genetic recombination technology and CDP technology,
such as natural moisturizing factor (PGA),
skin regeneration factor (EGF),
and skin cell growth factor (IGF).
Ministry of Science and ICT, 2022 Bio Risk Assessment One Team Renovation Project」
「Ministry of SMEs and Startups,
2022 Technology Development Innovation Project」
applications of
CDP technology
-
Skin antioxidant effect
- Cell protection, wrinkle regeneration, skin tone improvement, whitening
-
Skin cell
growth- Collagen generation,
skin wound healing, skin moisturizing,
skin barrier strengthening - Collagen generation,
-
Skin
regeneration- promotion of
epithelial cell growth,
skin elasticity enhancement,
skin moisturizing, skin barrier strengthening - promotion of
-
Production of
skin natural moisturizing factor- Skin moisturizing,
inhibition of melanin production - Skin moisturizing,
Business Registration No : 683-88-00195
E-commerce Permit : 2017-Seoul Gwanak_0869
Address : 08826) 1, Gwanak-ro, Gwanak-gu, Seoul (Silrim-dong) Seoul National University Biotechnology Joint Research Building 220, 6th floor, Room 639
Copyrightⓒ 2022 kanzen, ALL right reserved.
02-876-4633
Closed on Saturdays,
Sundays and public holidays
